Augie Ray@augieray@mastodon.social
People who experience #COVID19 "rebound" are at greater mortality risk, regardless of antiviral treatment.
STUDY: "Patients who experienced virologic rebound exhibited a significantly higher risk of post-acute mortality (hazard ratio [HR], 1.52)… compared with patients without virologic rebound. A similar increase in the risk of post-acute mortality is also observed in nirmatrelvir/ritonavir-treated patients (HR, 1.78) and molnupiravir-treated patients (HR, 1.47)."
https://www.nature.com/articles/s41467-025-61737-7